Nicorette Invisi Transdermal Patch Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Transparent patch for topical application available in sizes of 22.5 cm²/13.5 cm²/9.0 cm².
Nicorette Invisi Transdermal Patch 10 mg/15 mg/25 mg per 16 Hours is a semi-transparent, beige, imprinted, 9.0 cm²/13.5 cm²/22.5 cm², rectangular Transdermal Therapeutic System (TTS), with rounded corners. It consists of pre-coated backing layer, nicotine source layer, and a skin contact adhesive layer on a pre-coated aluminized and siliconized release liner and contains 15.75 mg/23.62 mg/39.37 mg nicotine.
Active Ingredient: Nicotine 1.75 mg/cm².
Excipients/Inactive Ingredients: Medium chain triglycerides, basic butylated methacrylate copolymer, polyethylenterephthalate film (PET), acrylic adhesive solution, potassium hydroxide, croscarmellose sodium, aluminium acetylacetonate, siliconized PET release liner with aluminized single side.

Nicorette Invisi Transdermal Patch Description

nicotine

Manufacturer:

JNTL

Distributor:

Zuellig Pharma